Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

about

Activation of ER Stress-Dependent miR-216b Has a Critical Role in Salviamiltiorrhiza Ethanol-Extract-Induced Apoptosis in U266 and U937 Cells.miR-211 Plays a Critical Role in Cnidium officinale Makino Extract-Induced, ROS/ER Stress-Mediated Apoptosis in U937 and U266 Cells.

P2860

Q52718358-71E42153-3F20-4806-8BB0-FF1665F178FB Q54121163-A70BBDD0-1F87-455D-A878-D7B791981268

P2860

Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

Item

http://www.wikidata.org/entity/Q50197484

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@en

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@nl

type

Item

label

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@en

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@nl

prefLabel

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@en

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@nl

P1476

Evaluation of thrombosis-relat ...... atients with multiple myeloma.

@en

P2093

Atsushi Satake

http://www.w3.org/2001/XMLSchema#string

Aya Nakaya

http://www.w3.org/2001/XMLSchema#string

Hideaki Yoshimura

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Ishii

http://www.w3.org/2001/XMLSchema#string

Masaaki Hotta

http://www.w3.org/2001/XMLSchema#string

Shinya Fujita

http://www.w3.org/2001/XMLSchema#string

Shosaku Nomura

http://www.w3.org/2001/XMLSchema#string

Takahisa Nakanishi

http://www.w3.org/2001/XMLSchema#string

Tomoki Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Efficacy and Safety of Novel Agent-Based Therapies for Multiple Myeloma: A Meta-Analysis

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Development and assessment of enzyme immunoassay for platelet-derived microparticles.

Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production.

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Endothelial stress products and coagulation markers in patients with multiple myeloma treated with lenalidomide plus dexamethasone: an observational study.

Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Shedding of membrane proteins by ADAM family proteases.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JBM.S147743

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29403323

http://www.w3.org/2001/XMLSchema#string

P932

5783022

http://www.w3.org/2001/XMLSchema#string

Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

about

P2860

P2860

Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932